NOT-DA-21-078: Notice of Early Expiration of PAR-21-023, "Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)"

Notice of Early Expiration of PAR-21-023, "Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)"

Notice Number:

NOT-DA-21-078

Key Dates

Release Date:

September 21, 2021

Related Announcements

PAR-21-02 3 - Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice informs the extramural community of a change in expiration date for Funding Opportunity Announcement (FOA) PAR-21-02 3 - Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional). The new expiration date for PAR-21-02 3 will be November 16, 2021.

Applicants wishing to conduct pilot system-level implementation research may consider responding to PA-21-180, Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional).

The following section of the FOA has been modified.

Currently Reads:

Part 1. Overview Information

Key Dates

Expiration Date

November 16, 2023

Revised to Read (changes shown in bold italics):

Part 1. Overview Information

Key Dates

Expiration Date
November 16, 2021

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Lori Ducharme, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6331
Email: Lori.Ducharme@nih.gov

Laura Kwako, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-451-8507
Email: Laura.Kwako@nih.gov